Publication
 2020 - 21  2018 - 19  2016 - 17  2014 - 15  2012 - 13
 2010 - 11  2008 - 09 2006 - 07  2001 - 05  - 2000 

2001 - 2005  

  • Wang, X., Ria, M., Kelmenson, P.M., Eriksson, P., Higgins, D.C., Samnegard, A., Petros, C., Rollins, J., Bennet, A.M., Wiman, B., Faire, U.D., Wennberg, C., Olsson, P.G., Ishii, N., Sugamura, K., Hamsten, A., Forsman-Semb, K., Lagercrantz, J. and Paigen, B.: Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet37: 365-372, 2005
  • Takeda, I., Murata, K., Killeen, N., Ndhlovu, L. C., Satomi, S., Sugamura, K. and Ishii, N.: Distinct roles for the OX40-OX40L interaction in regulatory and non-regulatory T cells. J. Immunol., 172: 3580-3589, 2004
  • Sugamura, K., Ishii, N. and Weinberg, A. D.: Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol4: 420-431, 2004
  • Horai, R., Nakajima, A., Habiro, K., Kotani, M., Nakae, S., Matsuki, T, Nambu, A., Saijo, S., Kotaki, H., Sudo, K., Okahara, A., Tanioka, H., Ikuse, T., Ishii, N., Schwartzberg, P.L., Abe, R., and Iwakura, Y.: TNFa is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J. Clin. Invest.114: 1603-1611, 2004
  • Andarini S, Kikuchi T, Nukiwa M, Pradono P, Suzuki T, Ohkouchi S, Inoue A, Maemondo M, Ishii N, Saijo Y, Sugamura K, and Nukiwa T.: Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances anti-tumor immunity of tumor-bearing hosts.Cancer Res.64: 3281-3287, 2004
  • Ishii, N., Ndhlovu, L.C., Murata, K., Sato, T., Kamanaka, M., and Sugamura, K.: OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses. Eur. J. Immunol33: 2372-2381, 2003
  • Murata, K., Nose, M., Ndhlovu, L. C., Sato, T., Sugamura, K. and Ishii, N.: Constitutive OX40-OX40 ligand interaction induces autoimmune-like diseases. J. Immunol., 169: 4628-4636, 2002
  • Yamada, M., Ishii, N., Asao, H., Murata, K., Kanazawa, C., Sasaki, H. and Sugamura, K.: Signal-transducing adaptor molecule STAM1 and STAM2 are required for T-cell development and survival. Mol. Cell. Biol., 22: 8648-8658, 2002
  • Sato, T., Ishii, N., Murata, K., Kikuchi, K., Nakagawa, S., Ndhlovu, L.C., and Sugamura K.: Consequences of OX40-OX40 ligand interactions in Langerhans cell function: Enhanced contact hypersensitivity responses in OX40L transgenic mice. Eur. J. Immunol.32: 3326-3335, 2002
  • Yamada, M., Takeshita, T., Miura, S., Murata, K., Kimura, Y., Ishii, N., Nose, M., Sakaguchi, H., Kondo, H., Tashiro, F., Miyazaki, J., Sasaki, H., and Sugamura, K.: Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1. Mol. Cell. Biol.21: 3807-3819, 2001
  • Ndhlovu, L. C., Ishii, N., Murata, K., Sato, T. and Sugamura, K.: Critical involvement of OX40 ligand signals in the T-cell priming events during experimental autoimmune encephalomyelitis. J. Immunol.,167: 2991-2999, 2001
  • Ishii, N., Owada, Y., Yamada, M., Miura, S., Murata, K., Asao, H., Kondo, H., and Sugamura, K.: Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient Mice. Mol. Cell. Biol.21: 8626-8637. 2001
  • Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., and Sugamura, K.: The common g-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol.167: 1-5, 2001
  • Kikuchi, K., Kawasaki, Y., Ishii, N., Sasaki, Y., Asao, H., Takeshita, T., Miyoshi, I., Kasai, N., and Sugamura, K., : Suppression of thymic development by the dominant-negative form of Gads. Int. Immunol13: 777-783, 2001

連絡先

東北大学大学院医学系研究科免疫学
〒980-8575
仙台市青葉区星陵町2-1

TEL 022-717-8096
FAX 022-717-8097

E-mail
ishiin(アット)med.tohoku.ac.jp